News

After slow start, demand for COVID monoclonal antibodies treatment skyrockets

Karen Weintraub, USA TODAY Comments Off on After slow start, demand for COVID monoclonal antibodies treatment skyrockets

Monoclonal antibodies can reduce the risk of severe COVID-19, but they've been underused. Demand has soared with the rise of the delta variant.

     
Karen Weintraub, USA TODAY
https://api-internal.usatoday.com.akadns.net

Related Articles
News

2017 in review: The ‘Wonder’-filled highs (and lows) of the year in movies

USA TODAY

USA TODAY looks at the highs (‘Wonder Woman’) and lows (‘Valerian and the City of a Thousand Planets’) of the year’s movies.
News

Shooter among dead in New Mexico high school shooting

The (Farmington, N.M.) Daily Times

Two students were killed when a shooter opened fire at Aztec High School.
News

Nativity scene and Christmas tree unveiled at the Vatican

Newslook

Nativity scene and Christmas tree unveiled at the Vatican Video provided by AFP